3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agent
-
Add time:09/03/2019 Source:sciencedirect.com
3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid and analogs were designed and synthesized as highly potent and selective CYP26 inhibitors, serving as retinoic acid metabolic blocking agents (RAMBAs), with demonstrated in vivo efficacy to increase the half-life of exogenous atRA.
We also recommend Trading Suppliers and Manufacturers of 1-cyclobutyl-7-(dimethylamino)-1-hydroxy-1-phenyl-5-heptyn-2-one (cas 136722-55-9). Pls Click Website Link as below: cas 136722-55-9 suppliers
Prev:Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine (cas 136706-33-7) but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or2-hydroxy-4,5-methylenedioxyamphetamine
Next:New neplanocin analogues. III. 6′R-configuration is essential for the antiviral activity of 6′-C-methyl-3-deazaneplanocin a's☆) - 【Back】【Close 】【Print】【Add to favorite 】